How to Define Significant Loss (When the DEA Won't)
What exactly qualifies as a "significant loss" of controlled substances? It's one of the most common—and most challenging—questions facing healthcare organizations. While the DEA requires reporting of significant losses, it intentionally does not provide a universal definition, leaving hospitals to determine what is appropriate for their own operations. In this episode of Drug Diversion Insights, Terri is joined by Calvin Parmiter, System Pharmacy Manager for Diversion and Compliance at West Virginia University Medicine, and Shannan Molnar, Drug Diversion Coordinator for multiple WVU Medicine facilities. Together, they discuss how their team developed a standardized approach to defining significant loss, reducing uncertainty and creating consistency across a large, multi-site health system. In this episode, we discuss: Why the DEA leaves "significant loss" undefined How WVU Medicine developed its own standardized reporting criteria Building a practical checklist to guide reporting decisions Reducing subjectivity during diversion investigations The challenges of managing diversion programs across multiple hospitals Standardizing processes while accounting for differences between large and rural facilities Preparing local leadership to respond when diversion specialists aren't on site Lessons learned from implementing a system-wide diversion program What worked, what didn't, and advice for organizations building their own programs Whether you're a diversion specialist, pharmacy leader, compliance officer, medication safety professional, nurse leader, or healthcare executive, this episode offers practical guidance for creating consistent, scalable diversion prevention practices across complex healthcare systems. If your organization has ever struggled with defining significant loss or standardizing diversion response across multiple sites, this conversation provides a roadmap built from real-world experience. 🔗 More from Rxpert Solutions https://www.rxpert.solutions/?utm_sou... Follow us: Facebook: / rxpertsolutions X (Twitter): / rxpertsolutions LinkedIn: / rxpertsolutions Spotify: https://open.spotify.com/show/6UwSCi8... #DrugDiversionPrevention #DEA #HealthcareCompliance #MedicationSafety #ControlledSubstances #HospitalPharmacy #DiversionMitigation #HealthcareLeadership #PatientSafety #PharmacyLeadership #RxpertSolutions

Surgeon Reveals: Do THIS 1 Exercise for Poor Leg Circulation After 60

The Findings That Surprised Me: Three DEA Inspections, One Pharmacy Leader

How to Build a Thriving Arts Education Program

Legal Diagnosis Episode 12

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

They Knew 432 Park Avenue Would Crack Before They Built It

We're NOT here for fun (BACK DAY)

ASC Accreditation: Avoiding Infection Control Citations l Custom Surgical Partners, Inc.

Deprescribing Principles for Pharmacists

Empowering Your Fertility Journey with Alik Christianian & Diana Canaan

What a Stroke Looks Like the Day Before It Hits — Know This to Protect Yourself

Doctor reveals undisclosed risks of COVID-19 vaccine

The AI Skills Nobody is Teaching (And Everyone Needs) | AI Expert Ethan Mollick

What the UK Gets Right About Drug Diversion That the US Doesn't

Former nurse speaks out after sentencing in fatal drug error | Nightline

How to Build a Sales Management System That Drives 30–100% Year Over Year Growth

S1, E9: Medicaid and Supporting Families of Children with Developmental Differences

🚔 Stopped by the Police? There's Only ONE Thing You MUST Do by Law — Here's What to Say

A Practical Guide for Operational Workers (End of Life of Digital Health Devices)

